Edward Amento

Sutter Hill Ventures LLC (Sutter Hill Ventures) is a venture capital firm founded in 1962 by Paul M Wythes and Bill H Draper. The firm is headquartered in Palo Alto, California.

Tecan Genomics, Inc. provides genomics sample preparation solutions. It offers solutions which make biological samples accessible for genomic analysis. The firm has commercialized numerous proprietary DNA and RNA sample preparation products for use in research and diagnostic applications. The company was founded by Jan D'Alvise, James W. Larrick and Nurith Kurn in 2000 and is headquartered in San Carlos, CA.

Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA.

Arbor Vita Corp. engages in discovery and developing of drugs. It targets cellular regulators, PDZ proteins, to accelerate the discovery and development of human therapeutics, and diagnostics. The company was founded by Peter S. Lu in 1998 and is headquartered in Fremont, CA.

Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA.

Xoft, Inc. develops Electronic Brachytherapy systems for radiation therapy applications. Its products include the Axxent Controller, which utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed; Axxent HDR X-ray Source, a low energy radiation treatment without the use of radioactive isotopes; Axxent Applicators, which provides a channel for the Axxent X-ray Source to deliver high dose rate, low energy radiation directly to the targeted area; and Axxent Accessories, an accessory product line designed to support and aid a physician during a procedure or treatment of cancer radiation. The company was founded by Michael Forman in 1998 and is headquartered in San Jose, CA.

AkaRx, Inc. engages in the develop and manufacture of biopharmaceutical products for applications in hematology and therapeutic treatments for clinical-stage cancer. It offers thrombocytopenia treatment avatrombopag. The company was founded by Robert E. Desjardins and Donna Tempel in 2005 and is headquartered in NJ.

Drais Pharmaceuticals, Inc. manufactures pharmaceutical and provides therapeutic treatments. The company was founded by Donna L. Tempel and Robert E. Desjardins in 2007 and is headquartered in Bridgewater, NJ.

Procyrion, Inc. manufactures medical devices. The firm develops percutaneous circulatory assist device intended to treat chronic heart failure. Its product Aortix is a catheter deployed circulatory assist device for the millions of heart failure patients who are too sick for medication alone. The company was founded by Reynolds M. Delgado III in 2005 and is headquartered in Houston, TX.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA.

Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million.

Stanford Health Care provides healthcare services. It services includes cardiac care, cancer treatment, neurosciences, surgery and organ transplants. The company was founded in 1956 and is headquartered in Stanford, CA.

Helix OpCo LLC is a genomics company. It offers consumer genetics, next generation sequencing (ngs), bioinformatics, consumer insights, big data, dna, population health, and genomics. The company was founded by Justin Kao, Scott Burke, Jay T Flatley and James Lu in 2015 and is headquartered in San Mateo, CA.

TeneoBio, Inc. operates as a biotechnology company that develops biologics, human heavy chain antibodies, as therapeutics against cancer, autoimmunity, and infectious diseases. Its products provides treatment of multiple myeloma, prostate cancer, immune disorders, and AIDS. The company was founded by Roland Buelow, on August 9, 2009 and is headquartered in Menlo Park, CA.

Agenovir Corp. provides research and developing novel antiviral therapeutics for diseases. The company was founded by Bruce Hironaka and Stephen R. Quake and is headquartered in San Francisco, CA.

Bluebird Ventures (Bluebird Ventures) is a venture capital firm founded in 2019 by Jeffrey Bird. The firm is headquartered in Palo Alto, California.

Foresight Diagnostics, Inc. is a privately held cancer diagnostics company based in Aurora, CO. The company has developed a liquid biopsy testing platform for the measurement of minimal residual disease (MRD) that is significantly more sensitive than existing tests, with a detection limit below 0.0001% or one part-per-million. This improved sensitivity provides actionable information to physicians and biopharmaceutical companies to enable more personalized treatment approaches for patients with a variety of cancers. The company's experts specialize in liquid biopsy and cancer genomics, developing an MRD assay centered on the detection of ctdna via phased variant sequencing. The company uses phased-seq® liquid biopsy technology for cancer relapse surveillance by monitoring cfdna/ctdna in the blood of lymphoma and lung cancer patients. The company was founded by Maximilian Diehn, Ash Alizadeh, Jake Chabon, and David Kurtz, with Jake Chabon serving as the CEO since incorporation.

Part of Theracos, Inc., IncreVet, Inc. develops veterinary drugs. The company is based in Marlborough, MA. The company was founded by Brian Connelly. IncreVet was acquired by Theracos, Inc. on January 31, 2022.

Merganser Biotech, Inc. engages in the development of of hepcidin mimetic peptides as new medicines for the treatment of hematological and iron overload diseases. The company was founded by Brian R. MacDonald and Gene Merutka in 2011 and is headquartered in Newtown Square, PA.